-
FDA's Prasad Cites Alleged Child COVID Shot Deaths in Push for Stricter Rules
Saturday, November 29, 2025 - 3:52pm | 745Read More...The Food and Drug Administration’s top vaccine regulator is pushing new limits on how vaccines win approval. The tougher standards could cloud prospects for vaccine makers and rattle investors in major healthcare and biotech names. Center for Biologics Evaluation and Research Director Vinay...
-
Robert F. Kennedy Jr.'s CDC Overhaul 'Critically Weakened' US Vaccine Program, Say Ousted Experts
Tuesday, June 17, 2025 - 6:33am | 428Read More...Fired vaccine experts warn that Health Secretary Robert F. Kennedy Jr.’s overhaul of the Centers for Disease Control and Prevention’s key vaccine advisory panel threatens public health and undermines decades of immunization progress. What Happened: Seventeen ousted members of the CDC...
-
RFK Jr. Champions 'Medical Freedom' While Curtailing Access, Say Public Health Experts
Friday, June 6, 2025 - 7:01am | 575Read More...U.S. Health Secretary Robert F. Kennedy Jr. has championed “medical freedom” while simultaneously limiting access to COVID-19 vaccines and restricting food stamp purchases, creating what public health experts call a dichotomy in his approach to healthcare policy. What Happened: Kennedy...
-
Trump-Era FDA Appointees Request New Trials For Novavax COVID Vaccine, Reportedly Delaying Approval Timeline
Tuesday, April 29, 2025 - 3:57am | 567Read More...The President Donald Trump administration’s request for Novavax Inc. (NASDAQ:NVAX) to conduct new clinical trials for its COVID-19 vaccine. What Happened: Novavax announced Monday that the Food and Drug Administration requested a new clinical trial before granting full approval for its...
-
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
Monday, September 16, 2024 - 11:18am | 596Read More...Florida Governor Ron DeSantis' administration has reportedly issued updated guidance recommending that healthcare providers steer vulnerable patients away from mRNA-based COVID-19 vaccines. The Florida Health Department is raising concerns about the safety of the mRNA vaccines, pointing to...
-
German Man Vaccinated Himself 217 Times Against COVID: Here's What Happened Next
Wednesday, March 6, 2024 - 11:03am | 570Read More...In a peculiar case, a 62-year-old man from Germany has reportedly received 217 COVID-19 vaccine doses, defying medical advice. The man has not suffered any adverse effects. What Happened: The man, who chose to remain anonymous, received the vaccines privately over a period of 29 months, reported...
-
Why Is Gritstone Bio Stock Trading Lower?
Friday, March 1, 2024 - 1:08pm | 341Read More...Gritstone bio Inc (NASDAQ:GRTS) shares are trading lower after the company announced an approximately 40% reduction of its workforce. The move comes following the recently announced delay of the proposed CORAL Phase 2b study, which resulted in Gritstone not receiving the external...
-
Walgreens Bites The Covid Dust
Tuesday, June 27, 2023 - 12:46pm | 582Read More...For the first time since July 2020, Walgreens Boots Alliance Inc (NASDAQ: WBA) missed earnings expectations. Besides its disappointing fiscal third-quarter results, the retail pharmacy chain also slashed its full year earnings guidance in the face of lower consumer spending and a drop in demand for...
-
Pfizer-BioNTech, Moderna Set To Get FDA Nod For Omicron Booster Shots As Early As Wednesday: Report
Tuesday, August 30, 2022 - 2:34am | 398Read More...Booster shots for Omicron variants of the novel coronavirus could officially be made available in the U.S. just after Labor Day, Politico reported on Monday. What Happened: The Food and Drug Administration (FDA) will likely authorize the booster shots of Pfizer, Inc. (NYSE: PFE)/BioNTech SE (NASDAQ...
-
Boosters And Mandate Could Increase Vaccine Demand
Tuesday, September 21, 2021 - 5:55pm | 1437Read More...This is an excerpt from Medically Necessary, a health care supply chain newsletter. Subscribe here. The news: A panel advising the Food and Drug Administration recommended approving COVID-19 booster shots only for people over age 65 and people who have a high risk of developing severe COVID-19...
-
Everest Joins Race to Make mRNA Covid Vaccines for China
Tuesday, September 21, 2021 - 3:56pm | 1184Read More...Key takeaways: Everest will pay up to $150 million or more to potentially bring an mRNA vaccine being developed by Canada’s Providence Therapeutics to China Deal comes as Beijing appears increasingly receptive to mRNA vaccines, even though Providence’s jabs have yet to be approved in...
-
Air Canada Mandates Employee Vaccination Against COVID-19
Wednesday, August 25, 2021 - 4:27pm | 286Read More...Air Canada (OTC: ACDVF) introduced a new health and safety policy, making it mandatory for all airline employees to be fully vaccinated against COVID-19 and report their vaccination status on October 30, 2021. Recently, the Government of Canada directed employees in the federally...
-
Tuesday's Market Minute: Markets Rally On FDA Vaccine Approval
Tuesday, August 24, 2021 - 10:10am | 358Read More...Investors may be scratching their heads at the resiliency shown by the major U.S. stock indices as of late. Despite the Delta variant unleashing renewed fears of economic shutdowns globally and other factors that should be dampening markets – supply chain issues, labor and semiconductor...
-
BioMedNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Receives FDA Clearance For mmRNA Oral Appliance
Monday, August 23, 2021 - 11:17am | 1026Read More...The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and...
-
Pfizer's Unusual Options Spotted
Friday, August 20, 2021 - 10:37am | 506Read More...Pfizer (NYSE:PFE) shares experienced unusual options activity on Friday. The stock price moved up to $49.6 following the option alert. Sentiment: BEARISH Option Type: SWEEP Trade Type: CALL Expiration Date: 2021-12-17 Strike Price: $50.00 Volume: 2914 Open Interest: 13281 Three Signs Of Unusual...















